Insider Trading disclosures for Immucell Corp.

The latest disclosure was made by Bryan K. Gathagan in Immucell Corp. where a trade of 10,000 Non-Qualified Stock Options (Right to buy) done was reported to US exchanges on Sept. 20, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Bryan K. Gathagan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Sep 2024	10,000	10,000	-		-	Non-Qualified Stock Options (Right to buy)
Gloria J. Basse	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Sep 2024	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
Steven T. Rosgen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Sep 2024	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
Paul R. Wainman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Sep 2024	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
David S. Tomsche	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Sep 2024	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 3.55 per share.	28 Aug 2024	2,186	131,797 (1%)	0%	3.5	7,760	Common stock $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 3.55 per share.	23 Aug 2024	6,005	129,611 (1%)	0%	3.6	21,318	Common stock $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 3.55 per share.	22 Aug 2024	10,000	123,606 (1%)	0%	3.6	35,500	Common stock $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 3.72 per share.	15 Aug 2024	4,811	110,434 (1%)	0%	3.7	17,883	Common stock $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 3.57 per share.	15 Aug 2024	2,017	105,623 (1%)	0%	3.6	7,195	Common stock $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 3.67 per share.	15 Aug 2024	3,172	113,606 (1%)	0%	3.7	11,641	Common stock $0.10 per value per share
Bryan K. Gathagan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jun 2023	15,000	15,000	-		-	Non-Qualified Stock Options (Right to buy)
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.24 per share.	13 Mar 2023	100	98,426 (1%)	0%	5.2	524	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.20 per share.	13 Mar 2023	10	98,326 (1%)	0%	5.2	52	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.24 per share.	13 Mar 2023	100	98,526 (1%)	0%	5.2	524	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.51 per share.	13 Mar 2023	71	98,597 (1%)	0%	5.5	391	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.50 per share.	13 Mar 2023	309	98,906 (1%)	0%	5.5	1,700	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.47 per share.	13 Mar 2023	831	99,737 (1%)	0%	5.5	4,546	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.20 per share.	13 Mar 2023	400	96,826 (1%)	0%	5.2	2,080	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.54 per share.	13 Mar 2023	69	99,906 (1%)	0%	5.5	382	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.52 per share.	13 Mar 2023	31	99,937 (1%)	0%	5.5	171	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.54 per share.	13 Mar 2023	69	100,006 (1%)	0%	5.5	382	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.52 per share.	13 Mar 2023	31	100,037 (1%)	0%	5.5	171	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.54 per share.	13 Mar 2023	69	100,106 (1%)	0%	5.5	382	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.52 per share.	13 Mar 2023	31	100,137 (1%)	0%	5.5	171	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.52 per share.	13 Mar 2023	31	100,168 (1%)	0%	5.5	171	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.54 per share.	13 Mar 2023	69	100,237 (1%)	0%	5.5	382	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.53 per share.	13 Mar 2023	100	100,337 (1%)	0%	5.5	553	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.54 per share.	13 Mar 2023	69	100,406 (1%)	0%	5.5	382	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.44 per share.	13 Mar 2023	100	100,506 (1%)	0%	5.4	544	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.53 per share.	13 Mar 2023	100	99,837 (1%)	0%	5.5	553	Common stock $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.29 per share.	13 Mar 2023	7	98,316 (1%)	0%	5.3	37	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.33 per share.	13 Mar 2023	3	98,309 (1%)	0%	5.3	16	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.34 per share.	13 Mar 2023	80	98,306 (1%)	0%	5.3	427	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.37 per share.	13 Mar 2023	900	98,226 (1%)	0%	5.4	4,833	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.25 per share.	13 Mar 2023	200	97,326 (1%)	0%	5.3	1,050	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 5.24 per share.	13 Mar 2023	300	97,126 (1%)	0%	5.2	1,572	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Dec 2022	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
David S. Cunningham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Dec 2022	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
Paul R. Wainman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Dec 2022	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
Steven T. Rosgen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Dec 2022	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
Gloria J. Basse	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Dec 2022	10,000	10,000	-		-	Non Qualified Stock Options (Right to buy)
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 7.80 per share.	08 Sep 2022	5	94,664 (1%)	0%	7.8	39	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 7.69 per share.	08 Sep 2022	260	94,924 (1%)	0%	7.7	1,999	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 8.00 per share.	08 Sep 2022	1	94,925 (1%)	0%	8	8	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 7.76 per share.	08 Sep 2022	647	95,572 (1%)	0%	7.8	5,021	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 7.79 per share.	08 Sep 2022	33	95,605 (1%)	0%	7.8	257	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 7.70 per share.	08 Sep 2022	20	95,625 (1%)	0%	7.7	154	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 7.75 per share.	08 Sep 2022	606	96,231 (1%)	0%	7.8	4,697	Common Stock, $0.10 per value per share
David S. Tomsche	Director	Sale or transfer of securities back to the company at price $ 7.80 per share.	08 Sep 2022	195	96,426 (1%)	0%	7.8	1,521	Common Stock, $0.10 per value per share

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

47.90% Gain from 52W Low

Insider Trading disclosures for Immucell Corp.

The latest disclosure was made by Bryan K. Gathagan in Immucell Corp. where a trade of 10,000 Non-Qualified Stock Options (Right to buy) done was reported to US exchanges on Sept. 20, 2024.

Screeners based on Insider Trading and SAST parameters